NCT05115929

Brief Summary

Intractable high intracranial pressures (ICP) are associated with poor functional outcomes and mortality, so the SCALPEL trials aims to evaluate the effect of decompressive craniectomy against decompressive laparotomy to lower those pressures in diffuse TBI. The primary outcome measure for that evaluation is functional outcome after 12 months on the extended Glasgow Outcome Scale (GOS-E).

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Oct 2022Aug 2026

First Submitted

Initial submission to the registry

October 10, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 10, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

3.2 years

First QC Date

October 10, 2021

Last Update Submit

May 14, 2023

Conditions

Keywords

Traumatic Brain InjuriesDecompressive CraniectomyDecompressive Laparotomy

Outcome Measures

Primary Outcomes (1)

  • Functional outcome measured by the extended Glasgow Outcome Scale (GOS-E)

    8 Good recovery Upper no current problems related to the brain injury that affect daily life; 7 Good recovery Lower minor problems that affect daily life; resumes \>50% of the pre-injury level of social and leisure activities; 6 Moderate disability Upper reduced work capacity; resumes \<50% of the pre-injury level of social and leisure activities; 5 Moderate disability Lower unable to work or only in sheltered workshop; 4 Sever disability Upper can be left alone \> 8h during the day, but unable to travel and/or go shopping without assistance; 3 Sever disability Lower requires frequent help of someone to be around at home most of the time every day; 2 Persistent vegetative state unresponsive and speechless; 1 Death \[higher scores mean better outcomes\]

    12 months post-injury

Secondary Outcomes (13)

  • Mortality

    30 days post-injury

  • Serious adverse events and surgical complications measured by the Clavien-Dindo Scale

    30 days post-injury

  • Frequency and severity of organ failure

    30 days post-injury

  • EQ-5D life quality

    6 and 12 months post-injury

  • GCS

    14 days post-injury

  • +8 more secondary outcomes

Study Arms (2)

Decompressive Craniectomy Group

ACTIVE COMPARATOR

participants with severe TBI randomly assigned as described in the study protocol

Procedure: Decompressive Craniectomy

Decompressive Laparotomy Group

ACTIVE COMPARATOR

participants with severe TBI randomly assigned as described in the study protocol

Procedure: Decompressive Laparotomy

Interventions

As described in the study protocol a long midline laparotomy is performed and open abdomen therapy using negative pressure dressings initiated to lower abdominal pressure and thereby improve venous return from the brain to lower intracranial pressure.

Decompressive Laparotomy Group

As described in the study protocol a sufficiently sized hemi-craniectomy is performed and the skin closed over the bony defect to allow cerebral swelling and thereby lower intracranial pressure.

Decompressive Craniectomy Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years
  • Traumatic Brain Injury with abnormal CT scan
  • Invasive ICP monitoring in place
  • ICP \>25 mmHg for 1-12h after conventional therapies step I and step II (see Trial flow chart)

You may not qualify if:

  • Bilateral fixed and dilated pupil
  • Limitation of therapies by the team due to poor prognosis
  • Withdrawal of consent
  • Severe pre-existing physical or mental disability or co-morbidity which would lead to a poor outcome even if the patient made a full recovery from the head injury
  • Intracranial injury mandating craniotomy/craniectomy in itself
  • Intraabdominal injury mandating laparotomy in itself

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

HIA Percy

Clamart, 92140, France

NOT YET RECRUITING

Bundeswehrzentralkrankenhaus Koblenz

Koblenz, 56072, Germany

NOT YET RECRUITING

Department of Neurosurgery - Klinikum rechts der Isar

Munich, 81675, Germany

RECRUITING

Bundeswehrkrankenhaus Ulm

Ulm, 89081, Germany

RECRUITING

Related Publications (1)

  • Kolbel B, Novotny A, Willms A, Kehl V, Meyer B, Mauer UM, Krieg SM. Study protocol for a multicenter randomized controlled pilot study on decompressive laparotomy vs. decompressive craniectomy for intractable intracranial pressure after traumatic brain injury: The SCALPEL study. Brain Spine. 2023 Sep 26;3:102677. doi: 10.1016/j.bas.2023.102677. eCollection 2023.

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Decompressive Craniectomy

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Decompression, SurgicalSurgical Procedures, OperativeCraniotomyNeurosurgical Procedures

Central Study Contacts

Sandro Krieg, PhD, MBA

CONTACT

Benny Kölbel, MD, MBA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2021

First Posted

November 10, 2021

Study Start

October 1, 2022

Primary Completion

December 1, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

May 16, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations